©The Author(s) 2026.
World J Hepatol. Feb 27, 2026; 18(2): 114346
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.114346
Published online Feb 27, 2026. doi: 10.4254/wjh.v18.i2.114346
Table 3 Multivariate analysis of estimated glomerular filtration rate abnormalities in patients with chronic hepatitis B at 48 weeks
| Variables | Univariable analysis | Multivariable analysis | ||||
| OR | 95%CI | P value | OR | 95%CI | P value | |
| Age (year) | 1.065 | 1.007-1.127 | 0.028 | 0.986 | 0.916-1.062 | 0.717 |
| Alb (g/L) | 0.818 | 0.720-0.929 | 0.002 | 0.882 | 0.749-1.039 | 0.133 |
| TG (mmol/L) | 0.120 | 0.022-0.648 | 0.014 | 0.128 | 0.018-0.880 | 0.037 |
| eGFR (mL/minute/1.73 m2) | 0.880 | 0.814-0.951 | 0.001 | 0.886 | 0.813-0.966 | 0.006 |
- Citation: Ma SP, Wang L, Zhang YL, Wan X, Liu Q, Tang YL, Malhi LR, Ge SF. Effects of tenofovir amibufenamide and entecavir on estimated glomerular filtration rate in treatment-naïve patients with chronic hepatitis B. World J Hepatol 2026; 18(2): 114346
- URL: https://www.wjgnet.com/1948-5182/full/v18/i2/114346.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i2.114346